The estimated Net Worth of Issac Silberman is at least $39 Thousand dollars as of 19 November 2019. Mr. Silberman owns over 1,000 units of Intec Parent Inc stock worth over $38,520 and over the last 5 years he sold NTEC stock worth over $500. In addition, he makes $0 as Independent Director at Intec Parent Inc.
Issac has made over 1 trades of the Intec Parent Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of NTEC stock worth $500 on 19 November 2019.
The largest trade he's ever made was selling 1,000 units of Intec Parent Inc stock on 19 November 2019 worth over $500. On average, Issac trades about 500 units every 0 days since 2019. As of 19 November 2019 he still owns at least 4,000 units of Intec Parent Inc stock.
You can see the complete history of Mr. Silberman stock trades at the bottom of the page.
Issac Silberman is Independent Director of the Company. He has served on our board of directors since April 2010. From 2007 through the end of 2016, Mr. Silberman also served as a special investment advisor at Sullam Holdings L.R. Ltd., a financial services corporation in the Lenny Recanati Group, focusing primarily on investments in high-tech, biotechnology and real estate companies. Mr. Silberman also serves as a director in other private Israeli companies, and has over 20 years of prior experience as an executive officer of various public and private companies. Mr. Silberman holds a B.A. in economics and accounting from Tel Aviv University in Tel Aviv, Israel, and he is a certified public accountant in Israel.
Issac Silberman is 67, he's been the Independent Director of Intec Parent Inc since 2010. There are 1 older and 6 younger executives at Intec Parent Inc. The oldest executive at Intec Parent Inc is John Kozarich, 70, who is the Chairman of the Board.
Issac's mailing address filed with the SEC is C/O INTEC PHARMA LTD., 12 HARTOM STREET, JERUSALEM, L3, 9777512.
Over the last 6 years, insiders at Intec Parent Inc have traded over $284,445 worth of Intec Parent Inc stock and bought 245,000 units worth $117,350 . The most active insiders traders include Pharma Technologies Ltd.Ore..., Roger Pomerantz, and Jeffrey A Meckler. On average, Intec Parent Inc executives and independent directors trade stock every 27 days with the average trade being worth of $1,864,936. The most recent stock trade was executed by Pharma Technologies Ltd.Ore... on 31 January 2020, trading 915,951 units of NTEC stock currently worth $283,945.
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.
Intec Parent Inc executives and other stock owners filed with the SEC include: